Abstrakt
This study measures the increment of health care expenditure (HCE) that can be attributed to technological progress and change in medical practice by using a residual approach and microdata. We examine repeated cross-sections of individuals experiencing an initial health shock at different point in time over a 10-year window and capture the impact of unobservable technology and medical practice to which they are exposed after allowing for differences in health and socioeconomic characteristics. We decompose the residual increment in the part that is due to the effect of delaying time to death, that is, individuals surviving longer after a health shock and thus contributing longer to the demand of care, and the part that is due to increasing intensity of resource use, that is, the basket of services becoming more expensive to allow for the cost of innovation. We use data from the Danish National Health System that offers universal coverage and is free of charge at the point of access. We find that technological progress and change in medical practice can explain about 60% of the increment of HCE, in line with macroeconomic studies that traditionally investigate this subject.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Health Economics |
Vol/bind | 31 |
Udgave nummer | 6 |
Sider (fra-til) | 1184-1201 |
ISSN | 1057-9230 |
DOI | |
Status | Udgivet - jun. 2022 |
Bibliografisk note
Funding Information:Funded by the EU's Horizon 2020 research and innovation program under the MSCA grant 832513. We are grateful for useful comments and discussion at one of the meetings of the Health Economics Study Group and at seminar presentations at the University of York and Imperial College London.
Publisher Copyright:
© 2022 The Authors. Health Economics published by John Wiley & Sons Ltd.